These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1965011)

  • 1. [Echocardiography studies for detection of cardiotoxic side effects of anthracycline therapy in childhood].
    Richter R; Grumpelt U; Mittler U; Kluba U
    Monatsschr Kinderheilkd; 1990 Dec; 138(12):823-7. PubMed ID: 1965011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH.
    Marx M; Langer T; Graf N; Hausdorf G; Stöhr W; Ludwig R; Beck JD
    Med Pediatr Oncol; 2002 Jul; 39(1):18-24. PubMed ID: 12116074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers.
    Gupta M; Steinherz PG; Cheung NK; Steinherz L
    Med Pediatr Oncol; 2003 Jun; 40(6):343-7. PubMed ID: 12692800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer].
    Oberholzer K; Kunz RP; Dittrich M; Thelen M
    Rofo; 2004 Sep; 176(9):1245-50. PubMed ID: 15346258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.
    Elbl L; Hrstkova H; Chaloupka V; Novotny J; Michalek J
    Neoplasma; 2003; 50(3):191-7. PubMed ID: 12937852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
    Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
    Paulides M; Kremers A; Stöhr W; Bielack S; Jürgens H; Treuner J; Beck JD; Langer T;
    Pediatr Blood Cancer; 2006 Apr; 46(4):489-95. PubMed ID: 16333817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
    Rathe M; Carlsen NL; Oxhøj H
    Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.
    van Dalen EC; van der Pal HJ; Kok WE; Caron HN; Kremer LC
    Eur J Cancer; 2006 Dec; 42(18):3191-8. PubMed ID: 16987655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac function in Wilms' tumor survivors.
    Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I
    J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
    Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
    Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of late cardiac toxicity of anthracycline in childhood].
    Butera G; Piciacchia D; Chessa M; Condoluci C; Tornesello A; Delogu AB; Mastrangelo S; Cipriani A
    Minerva Pediatr; 1998 Apr; 50(4):111-9. PubMed ID: 9808963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare.
    Ward KM; Binns H; Chin C; Webber SA; Canter CE; Pahl E
    J Heart Lung Transplant; 2004 Sep; 23(9):1040-5. PubMed ID: 15454169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin cardiomyopathy in children with left-sided Wilms tumor.
    Pinkel D; Camitta B; Kun L; Howarth C; Tang T
    Med Pediatr Oncol; 1982; 10(5):483-8. PubMed ID: 6292680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-wave voltage in the right precordial leads in anthracycline cardiomyopathy: a clinical study.
    Onouchi Z; Tamiya H; Sakakibara Y; Ando M; Fujimoto T
    Int J Clin Pharmacol Res; 1988; 8(6):423-31. PubMed ID: 3253219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?].
    Erlaky H; Tóth K; Szabolcs J; Horváth E; Kemény V; Müller J; Csóka M; Jókúti L; Erdélyi D; Kovács G
    Magy Onkol; 2006; 50(1):25-32. PubMed ID: 16617380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late cardiotoxicity of anthracyclines in children with acute leukemia.
    Zalewska-Szewczyk B; Lipiec J; Bodalski J
    Klin Padiatr; 1999; 211(4):356-9. PubMed ID: 10472576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.